{"id":"W1980766188","doi":"10.1158/0008-5472.sabcs-09-6093","title":"First-Line Bevacizumab (Bev) Combination Therapy in Triple-Negative (TN) Locally Recurrent/Metastatic Breast Cancer (LR/MBC): Subpopulation Analysis of Study MO19391 in >2000 Patients (Pts).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Bevacizumab; Taxane; Capecitabine; Population; Oncology; Regimen; Combination therapy; Clinical endpoint; Metastatic breast cancer; Anthracycline; Cancer; Gastroenterology; Breast cancer; Chemotherapy; Randomized controlled trial; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001161853,0.0004546831,0.0007762882,0.0003145891,0.000216181,0.0004433072,0.0003393165,0.0003706792,0.001232577],"category_scores_gemma":[0.0009855579,0.0002406904,0.0009628197,0.0004928436,0.000251092,0.0002872767,0.0003047312,0.0005688092,0.0002263105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006451993,"about_ca_system_score_gemma":0.0004930019,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001569321,"about_ca_topic_score_gemma":0.003404395,"domain_scores_codex":[0.9995449,0.0002269628,0.00003922655,0.00008789352,0.00005263188,0.00004833086],"domain_scores_gemma":[0.9993999,0.0001113841,0.0002511072,0.00007945584,0.00002941069,0.00012866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3032394,0.009781843,0.5882761,0.0007339574,0.009246804,0.0005926323,0.0004746526,0.001369283,0.02202389,0.0001346589,0.001879983,0.06224681],"study_design_scores_gemma":[0.05240395,0.107911,0.8204013,0.00009032299,0.006571212,0.001456356,0.0002778103,0.002303335,0.004099147,0.0001999478,0.004236586,0.0000489868],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987795,0.0005284565,0.00007590048,0.0000257988,0.000003992755,0.00008910529,0.0003078931,0.000003876619,0.0001855326],"genre_scores_gemma":[0.9984397,0.0002593478,0.0001485366,0.0000537817,0.00001747109,0.00009397289,0.0007684952,0.000002982544,0.0002156615],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001569321,"threshold_uncertainty_score":0.006144583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1122721664816359,"score_gpt":0.4749909861458341,"score_spread":0.3627188196641982,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}